Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages

Cancer Biology and Therapy

Volumn 16, Issue 8, 2015, Pages 1205-1213

  Choi, Judy ^a,b   Stradmann Bellinghausen, Beate ^a   Yakubov, Eduard ^c   Savaskan, Nicolai E ^c   Regnier Vigouroux, Anne ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Glioblastoma; Glutamate; Monocyte derived macrophages; Tumor associated microglia macrophages

Indexed keywords

AMPA RECEPTOR; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; INTERLEUKIN 10; VASCULOTROPIN; AIF1 PROTEIN, HUMAN; CD11B ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; DNA BINDING PROTEIN; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2; ITGAM PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PTPRC PROTEIN, HUMAN;

ADULT; ARTICLE; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION ASSAY; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; MACROPHAGE; MICROGLIA; MONOCYTE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ASTROCYTE; BRAIN TUMOR; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE;

ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ASTROCYTES; BRAIN NEOPLASMS; COCULTURE TECHNIQUES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GLIOBLASTOMA; GLUTAMIC ACID; HUMANS; MACROPHAGES; MICROGLIA; RECEPTORS, AMPA; TUMOR CELLS, CULTURED;

EID: 84983461877     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2015.1056406     Document Type: Article

References (41)

1. Robert SM, Sontheimer H. Glutamate transporters in the biology of malignant gliomas. Cell Mol Life Sci 2014; 71:1839-54; PMID:24281762; http://dx.doi.org/10.1007/s00018-013-1521-z
2. Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H. Glutamate release by primary brain tumors induces epileptic activity. Nat Med 2011; 17:1269-74; PMID:21909104
3. Savaskan NE, Heckel A, Hahnen E, Engelhorn T, Doerfler A, Ganslandt O, Nimsky C, Buchfelder M, Eyupoglu IY. Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med 2008; 14:629-32; PMID:18469825; http://dx.doi.org/10.1038/nm1772
4. Ye ZC, Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 1999; 59:4383-91; PMID:10485487
5. Roggendorf W, Strupp S, Paulus W. Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 1996; 92:288-93; PMID:8870831; http://dx.doi.org/10.1007/s004010050520
6. Rossi ML, Hughes JT, Esiri MM, Coakham HB, Brownell DB. Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol 1987; 74:269-277; PMID:3314311
7. Glass R, Synowitz M. CNS macrophages and peripheral myeloid cells in brain tumours. Acta Neuropathol 2014; 128:347-62; PMID:24722970; http://dx.doi.org/10.1007/s00401-014-1274-2
8. Li W, Graeber MB. The molecular profile of microglia under the influence of glioma. Neuro Oncol 2012; 14:958-78; PMID:22573310; http://dx.doi.org/10.1093/neuonc/nos116
9. Ding P, Wang, W, Wang J, Yang Z, Xue L. Expression of tumor-associated macrophage in progression of human glioma. Cell Biochem Biophys 2014; 70:1625-31; PMID:25182001; http://dx.doi.org/10.1007/s12013-014-0105-3
10. Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 2008; 216:15-24; PMID:18553315; http://dx.doi.org/10.1002/path.2370
11. Gabrusiewicz K, Ellert-Miklaszewska A, Lipko M, Sielska M, Frankowska M, Kaminska B. Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS One 2011; 6:e23902; PMID:21901144
12. Kostianovsky AM, Maier LM, Anderson RC, Bruce JN, Anderson DE. Astrocytic regulation of human monocytic/microglial activation. J Immunol 2008; 181:5425-32; PMID:18832699; http://dx.doi.org/10.4049/jimmunol.181.8.5425
13. Hagino Y, Kariura Y, Manago Y, Amano T, Wang B, Sekiguchi M, Nishikawa K, Aoki S, Wada K, Noda M. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia. Glia 2004; 47:68-77; PMID:15139014
14. Noda M, Nakanishi H, Nabekura J, Akaike N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 2000; 20:251-8; PMID:10627602
15. Gras G, Samah B, Hubert A, Leone C, Porcheray F, Rimaniol A-C. EAAT expression by macrophages and microglia: still more questions than answers. Amino Acids 2012; 42:221-9; PMID:21373769; http://dx. doi.org/10.1007/s00726-011-0866-6
16. Rodrigues JC, Gonzalez GC, Zhang L, Ibrahim G, Kelly JJ, Gustafson MP, Lin Y, Dietz AB, Forsyth PA, Yong VW, et al. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol 2010; 12:351-65; PMID:20308313; http://dx.doi.org/10.1093/neuonc/nop023
17. Beschorner R, Dietz K, Schauer N, Mittelbronn M, Schluesener HJ, Trautmann K, Meyermann R, Simon P. Expression of EAAT1 reflects a possible neuroprotective function of reactive astrocytes and activated microglia following human traumatic brain injury. Histol Histopathol 2007; 22:515-26; PMID:17330806
18. Chretien F, Vallat-Decouvelaere A-V, Bossuet C, Rimaniol A-C, Le Grand R, Le Pavec G, Creminon C, Dormont D, Gray F, Gras G. Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaques. Neuropathol Appl Neurobiol 2002; 28:410-7; PMID:12366822; http:// dx.doi.org/10.1046/j.1365-2990.2002.00426.x
19. Pampliega O, Domercq M, Soria FN, Villoslada P, Rodrıguez-Antiguedad A, Matute C. Increased expression of cystine/glutamate antiporter in multiple sclerosis. J Neuroinflammation 2011; 8:63; PMID:21639880; http://dx.doi.org/10.1186/1742-2094-8-63
20. Nabeyama A, Kurita A, Asano K, Miyake Y, Yasuda T, Miura I, Nishitai G, Arakawa S, Shimizu S, Wakana S, et al. xCT deficiency accelerates chemically induced tumorigenesis. Proc Natl Acad Sci U S A 2010; 107:6436-41; PMID:20308543; http://dx.doi.org/10.1073/pnas.0912827107
21. Mesci P, Zaïdi S, Lobsiger CS, Millecamps S, Escartin C, Seilhean D, Sato H, Mallat M, Boillee S. System xC-is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Brain 2015; 138:53-68; PMID:25384799; http://dx.doi.org/10.1093/brain/awu312
22. Porcheray F, Leone C, Samah B, Rimaniol AC, Dereuddre-Bosquet N, Gras G. Glutamate metabolism in HIV-infected macrophages: implications for the CNS. Am J Physiol Cell Physiol 2006; 291:C618-26; PMID:16687472; http://dx.doi.org/10.1152/ajpcell.00021.2006
23. Kees T, Lohr J, Noack J, Mora R, Gdynia G, Todt G, Ernst A, Radlwimmer B, Falk CS, Herold-Mende C, et al. Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation. Neuro Oncol 2012; 14:64-78; PMID:22015597; http://dx.doi.org/10.1093/neuonc/nor182
24. Hussain SF, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol 2006; 8:261-79; PMID:16775224; http://dx.doi.org/10.1215/15228517-2006-008
25. Muller A, Brandenburg S, Turkowski K, Muller S, Vajkoczy P. Resident microglia, and not peripheral macrophages, are the main source of brain tumor mononuclear cells. Int J Cancer 2014 Dec 5; 137:278-88; PMID:25477239.; http://dx.doi.org/10.1002/ijc.29379. [Epub ahead of print]
26. Zhai H, Heppner FL, Tsirka SE. Microglia/macro-phages promote glioma progression. Glia 2011; 59:472-85; PMID:21264953; http://dx.doi.org/10.1002/glia.21117
27. Buckingham SC, Robel S. Glutamate and tumor-associated epilepsy: Glial cell dysfunction in the peritumoral environment. Neurochem Int 2013; 63:696-701; PMID:23385090; http://dx.doi.org/10.1016/j.neuint.2013.01.027
28. Beppu K, Kosai Y, Kido MA, Akimoto N, Mori Y, Kojima Y, Fujita K, Okuno Y, Yamakawa Y, Ifuku M, et al. Expression, subunit composition, and function of AMPA-type glutamate receptors are changed in activated microglia: possible contribution of GluA2 (GluR-B)-deficiency under pathological conditions. Glia 2013; 61:881-91; PMID:23468421; http://dx.doi.org/10.1002/glia.22481
29. Noda M, Beppu K. Possible contribution of microglial glutamate receptors to inflammatory response upon neurodegenerative diseases. J Neurol Disord 2013; 1:131; PMID:2329; http://dx.doi.org/10.4172/2329-6895.1000131
30. Nakajima K, Kanamatsu T, Takezawa Y, Kohsaka S. Up-regulation of glutamine synthesis in microglia activated with endotoxin. Neurosci Lett 2015; 591:99-104; PMID:25681623; http://dx.doi.org/10.1016/j.neulet.2015.02.021
31. Domercq M, Vazquez-Villoldo N, Matute C. Neurotransmitter signaling in the pathophysiology of microglia. Front Cell Neurosci 2013; 7:49; PMID:23626522
32. Liu GJ, Nagarajah R, Banati RB, Bennett MR. Glutamate induces directed chemotaxis of microglia. Eur J Neurosci 2009; 29:1108-18; PMID:19302147; http://dx.doi.org/10.1111/j.1460-9568.2009.06659.x
33. Rimaniol AC, Haïk S, Martin M, Le Grand R, Boussin FD, Dereuddre-Bosquet N, Gras G, Dormont D. NaC-dependent high-affinity glutamate transport in macrophages. J Immunol 2000; 164:5430-8; PMID:10799909; http://dx.doi.org/10.4049/jimmunol.164.10.5430
34. Bridges RJ, Natale NR, Patel SA. System xcˉ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol 2012; 165:20-34; PMID:21564084; http://dx.doi.org/10.1111/j.1476-5381.2011.01480.x
35. Lewerenz J, Klein M, Methner A. Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xcˉ protects from oxidative glutamate toxicity. J Neurochem 2006; 98:916-25; PMID:16771835; http://dx.doi.org/10.1111/j.1471-4159.2006.03921.x
36. Savaskan NE, Eyupoglu IY. xCT modulation in gliomas: relevance to energy metabolism and tumor micro-environment normalization. Ann Anat 2010; 192:309-13; PMID:20801625; http://dx.doi.org/10.1016/j.aanat.2010.07.003
37. Wolf IM, Fan Z, Rauh M, Seufert S, Hore N, Buchfelder M, Savaskan NE, Eyupoglu IY. Histone deacety-lases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration. Sci Rep 2014; 4:6226; PMID:25228443; http://dx.doi.org/10.1038/srep06226
38. Jung S, Schwartz M. Non-identical twins - microglia and monocyte-derived macrophages in acute injury and autoimmune inflammation. Front Immunol 2012; 3:89; PMID:22566968; http://dx.doi.org/10.3389/fimmu.2012.00089
39. Smith AM, Gibbons HM, Lill C, Faull RL, Dragunow M. Isolation and culture of adult human microglia within mixed glial cultures for functional experimentation and high-content analysis. Methods Mol Biol 2013; 1041:41-51; PMID:23813368
40. Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, Unterberg A, Herold-Mende C. Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 2006; 118:2182-9; PMID:16331629; http://dx.doi.org/10.1002/ijc.21648
41. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262